Clinical perspective on aztreonam lysine for inhalation in patients with cystic fibrosis
Martha K Daddario1, Jennifer K Hagerman2, Michael E Klepser21Spectrum Health, Grand Rapids, Michigan; 2Ferris State University College of Pharmacy, Kalamazoo, Michigan, USAAbstract: Progressive obstructive lung disease is a characteristic component of cystic fibrosis (CF). It is the pulmonary manife...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2010-10-01
|
| Series: | Infection and Drug Resistance |
| Online Access: | http://www.dovepress.com/clinical-perspective-on-aztreonam-lysine-for-inhalation-in-patients-wi-a5562 |